|
|
||||||||
Departments of 1 Pediatrics and 2 Surgery and the Cardiovascular Center, University of Iowa, Iowa City, Iowa 52242
| |
ABSTRACT |
|---|
|
|
|---|
Studies were performed to test the
hypothesis that the absence of adrenal glucocorticoids late in
gestation alters sympathetic and baroreflex responses before and
immediately after birth. Fetal sheep at 130-131 days gestation
(term 145 days) were subjected to bilateral adrenalectomy before the
normal prepartum increase in plasma cortisol levels. One group of
fetuses (n = 5) received physiological cortisol
replacement with a continuous infusion of hydrocortisone (2 mg · day
1 · kg
1 for 10 days), whereas the other group received 0.9% NaCl vehicle (n = 5). All animals underwent a second surgery 48 h before the study for placement of a renal nerve recording electrode.
Heart rate (HR), mean arterial blood pressure (MABP), renal sympathetic nerve activity (RSNA), and baroreflex control of HR and RSNA were studied before and after cesarean section delivery. At the time of
study (140-141 days gestation), fetal plasma cortisol
concentration was undetectable in adrenalectomized (ADX) fetuses and
58 ± 9 ng/ml in animals receiving cortisol replacement (ADX + F). Fetal and newborn MABP was significantly greater in ADX + F
relative to ADX animals. One hour after delivery, MABP increased
13 ± 3 mmHg and RSNA increased 91 ± 12% above fetal values
in ADX + F (both P < 0.05) but remained unchanged
in ADX lambs. The midpoint pressures of the fetal HR and RSNA
baroreflex function curves were significantly greater in ADX + F
(54 ± 3 and 56 ± 3 mmHg for HR and RSNA curves,
respectively) than ADX fetuses (45 ± 2 and 46 ± 3 mmHg).
After delivery, the baroreflex curves reset toward higher pressure in
ADX + F but not ADX lambs. These results suggest that adrenal
glucocorticoids contribute to cardiovascular regulation in the
late-gestation fetus and newborn by modulating arterial baroreflex
function and sympathetic activity.
cardiovascular; glucocorticoids; newborn; renal sympathetic nerve activity
| |
INTRODUCTION |
|---|
|
|
|---|
ANTENATAL ADMINISTRATION of glucocorticoids is widely used to improve lung maturity and function in premature infants and has resulted in improved clinical outcomes in this group of patients. In addition to promoting lung development, antenatal glucocorticoids have significant effects on postnatal cardiovascular, renal, and endocrine functions (5, 9, 10). The mechanisms by which glucocorticoids facilitate postnatal circulatory function are uncertain but may be related to augmented vascular, cardiac, humoral, and autonomic functions.
Glucocorticoids result in significant abnormalities in vascular function, enhancing responsiveness to vasoconstrictors while reducing the activity of depressor systems (25, 41). However, in addition to these peripheral mechanisms, there are reasons to believe that neural mechanisms may also be involved in the blood pressure response to glucocorticoids. Central administration of hydrocortisone increases blood pressure and sympathetic activity in adult rats (36). Glucocorticoids also modulate baroreflex control of heart rate (HR) and renal sympathetic nerve activity (RSNA) and enhance the pressor effect of central administration of ANG II, likely through augmenting activation of the sympathetic nervous system (26-28). Our laboratory previously reported that antenatal administration of glucocorticoids increases the RSNA response at birth in prematurely delivered lambs and decreases the sensitivity of the HR baroreflex (30).
Glucocorticoids stimulate cytodifferentiation and induce expression of developmentally regulated proteins in a large number of tissues (3). Concerns have recently been expressed regarding repetitive courses of corticosteroids and the potential for long-term detrimental effects related to antenatal glucocorticoid exposure. In particular, data from a variety of sources suggest that prenatal glucocorticoid exposure may predispose an individual to hypertension later in life (4, 20). Understanding the mechanisms by which glucocorticoids alter cardiovascular function in the fetus and newborn is critically important. Studies of the effects of glucocorticoids on central autonomic function early in life may provide an important contribution to the etiology of hypertension in the adult. The present study was therefore designed to test the hypothesis that fetal adrenal cortisol production modulates developmental changes in arterial baroreflex function and sympathetic drive after birth. More specifically, we examined the effects of fetal adrenalectomy without (ADX) and with physiological cortisol replacement (ADX + F) on birth-related changes in systemic hemodynamics, RSNA, and baroreflex control of HR and RSNA in lambs delivered near term by cesarean section.
| |
METHODS |
|---|
|
|
|---|
Studies were performed on conscious, chronically instrumented fetal sheep. Pregnant ewes of Dorset and Suffolk mixed breeding were obtained from a local source; gestational ages were based on the induced ovulation technique as previously described (13). All surgical and experimental procedures were performed within the regulation of the Animal Welfare Act and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The Guiding Principles in the Care and Use of Animals approved by the Council of the American Physiological Society and governed by the Animal Care and Use Committee of the University of Iowa were strictly adhered to.
Surgical preparations. The initial surgery, consisting of vascular catheter placement and bilateral adrenalectomy, was performed at 130-131 days gestation (term 145 days). This timing of surgery was chosen as it is before the beginning of the normal increase in plasma cortisol levels that occurs in sheep beginning ~2 wk before parturition (16). Briefly, after induction with 12 mg/kg of thiopental sodium (Abbott Laboratories, North Chicago, IL), anesthesia was maintained using a mixture of halothane (1%), oxygen (33%), and nitrous oxide (66%). After a maternal abdominal flank incision was performed, the uterus was partially externalized and opened over the fetal hindlimbs. Polyethylene catheters were placed into the fetal femoral arteries and veins bilaterally. A catheter for recording amniotic pressure was also secured to the fetal skin. With the use of a retroperitoneal approach, the adrenal was isolated, the vascular supply was ligated with suture, and the organ was removed. The flank incision was closed, the fetus was gently rotated, and the process was repeated on the other side. The fetus was returned to the uterus and after closure of all incisions, catheters were exteriorized through subcutaneous tunnels and placed in a cloth pouch on the ewe's flank. Ampicillin sodium was administered to the ewe intramuscularly before surgery (2 g) and infused into the amniotic cavity following surgery (2 g). After surgery, pregnant ewes were returned to individual pens and allowed free access to food and water. During the 3 days after surgery, the ewe received ampicillin sodium (1 g/day im).
The day following this initial surgery, fetuses were randomly chosen to receive cortisol replacement (Solu-Cortef, Upjohn, Kalamazoo, MI) or 0.9% NaCl vehicle at a constant infusion volume of 0.1 ml/min. The rate of cortisol replacement (~2 mg · day
1 · kg
1 estimated
fetal weight) has previously been shown to achieve plasma cortisol
levels that are within the range present in the fetus during late
gestation (39). One week after the initial surgery,
fetuses underwent a second surgery for placement of a recording
electrode on the renal nerve. This surgery, again performed under
general anesthesia as described above, was necessary as we have been
unable to reproducibly obtain good quality fetal renal nerve recordings
beyond 5 days after placement of electrodes. For this second surgery,
the left kidney, renal artery, and renal nerves were exposed through a
flank incision, and a plastic-coated copper wire, used as a ground
wire, was secured in the paravertebral muscle. After isolating a branch
of the left renal nerve bundle, platinum electrodes were secured onto
the nerve for recording of RSNA as described previously
(35). Function of the renal nerve was tested by audible
monitoring of pulse-synchronous bursts of neural activity and by
examining oscilloscope tracings during bolus phenylephrine infusion.
When function was demonstrated, electrodes were secured using Sil-Gel
(Sil-Gel 604A and 604B, Wacker-Chemie, Munich, Germany), and the flank
incision was closed in separate layers. Cortisol replacement was
continued throughout surgery and during the first part of the
physiological studies described below. Forty-eight hours were allowed
for recovery from surgery before experiments were performed.
Physiological studies.
Before the start of the experiments, the ewe was transferred to the
laboratory in a small cart that was placed in a Faraday cage. The
pregnant ewe was then sedated with diazepam (0.3 mg/kg), given an
intravenous bolus infusion of vecuronium bromide (0.1 mg/kg),
intubated, and ventilated to maintain venous blood gas values similar
to those obtained during spontaneous respiration. Muscle paralysis was
necessary to eliminate movements that interfere with nerve recording.
Maternal sedation with diazepam and paralysis had no effect on fetal
HR, arterial pressure, or plasma catecholamine concentrations
(unpublished data). Diazepam was administered every 2 h while
additional doses of vecuronium (0.1 mg/kg) were administered when
movement was detected. During the experiments, a constant infusion of a
solution of 5% dextrose and 0.2% NaCl was administered to the ewe at
a rate of 125 ml/h and to the fetus at 100 ml · kg
1 · day
1. After
intubation of the ewe, a 1-h stabilization period was allowed before
the start of the experiment.
Experimental protocol.
Fetal baseline values for HR, MABP, and RSNA were continuously recorded
and averaged over 30 min. Fetal arterial blood for determination of
blood gases and pH as well as plasma norepinephrine, epinephrine,
cortisol, ANG II, and arginine vasopressin (AVP) levels were obtained
at the completion of the baseline period. The volume of blood sampled
from the fetus was replaced immediately with an equivalent volume of
maternal blood to avoid any hemodynamic effects of sampling. Baroreflex
function in the fetus was then determined by producing ramp changes in
MABP with a continuous intravenous infusion of progressive doses of
phenylephrine or nitroprusside (1-30
µg · kg
1 · min
1 over a 5- to 7-min period using a Harvard infusion pump) while simultaneously
recording HR and RSNA. A 40- to 60-min recovery period was allowed for
MABP, HR, and RSNA to return to baseline values before the alternative
drug was administered. At the completion of the baroreflex studies, the
amount of background noise in the fetal nerve signal was assessed by
inhibiting nerve activity using an intravenous infusion of the
ganglionic blocking agent tetraethylammonium bromide (10 mg/kg).
Analytic procedures. Arterial blood for pH, PCO2, and PO2 was collected anaerobically in heparinized syringes, and measurements were immediately determined using a BGM 1302 pH/blood gas analyzer (Instrumentation Laboratory, Lexington, MA). All blood gas values were corrected for fetal temperature. Measurements of plasma AVP and ANG II were determined by radioimmunoassay (University of Wisconsin School of Veterinary Medicine Radioimmunoassay Laboratory, Dr. M. Brownfield, Director). Plasma norepinephrine, epinephrine, and cortisol concentrations were determined by radioimmunoassay in our laboratory using commercially available kits according to the manufacturer's specifications (Katcombi RIA RE29291, KMI Diagnostics, Minneapolis, MN and Cortisol RIA kit, Diagnostic Products, Los Angeles, CA).
Computation and data analysis.
RSNA was integrated and corrected by subtracting the background noise
level obtained in the presence of ganglionic blockade. RSNA was
normalized for each animal and expressed as the percentage of activity
observed in the fetus; the amount of activity measured during the
initial fetal baseline period was defined as 100%. Baroreflex
function, expressed as the relationship between MABP and HR or
integrated RSNA, was analyzed using a logistic sigmoid function (Sigma
Plot, SPSS Science, Chicago, IL) according to the equation RSNA or
HR = P4 + P1/{1 + exp[P2(MABP
P3)]}, where P1 is the
range between the upper and lower plateaus, P2
is a coefficient to calculate the gain as a function of pressure,
P3 is the MABP at midrange of the curve, and
P4 is the lower plateau (14). The
gain was calculated as the first derivative of the above equation.
Statistical analyses of differences in HR, MABP, RSNA, baroreflex
parameters, plasma hormone concentrations, and arterial blood gas
values during the described study periods were performed using a
two-way, repeated-measures analysis of variance, factoring for
treatment group and time. If the F statistic was found to be
significant (P < 0.05), comparison among means was performed by the Bonferroni t-test for multiple comparisons.
Data exhibiting a lack of homogeneity of variances among groups were analyzed nonparametrically using the Kruskal-Wallis test. Differences were considered significant when P < 0.05. All results
are expressed as means ± SE.
| |
RESULTS |
|---|
|
|
|---|
Arterial pH and blood gas values.
Fetal arterial pH, PO2, and
PCO2 were similar between the two groups (Table
1). Similar increases in
PO2 occurred in both groups after birth.
PCO2 significantly decreased after birth in both groups, although newborn values did not differ between ADX and
ADX + F lambs. Fetal arterial pH was also similar in both groups.
After delivery, pH remained similar to fetal values in the ADX group.
However, arterial pH was significantly greater after birth in the
ADX + F compared with ADX lambs.
|
Effect of adenalectomy and cortisol replacement on baseline
hemodynamics and RSNA.
The changes in HR, MABP, and RSNA occurring with delivery in ADX and
ADX + F sheep are shown in Table 2.
HR was similar in both fetal groups and increased after birth in
ADX + F but not ADX lambs (P < 0.05). MABP was
significantly lower in ADX compared with ADX + F fetuses. After
delivery, MABP did not increase in ADX animals (44 ± 2 vs.
44 ± 3 mmHg for fetus and 1-h newborn, respectively), whereas
MABP significantly increased after birth in ADX + F lambs and
remained elevated for the duration of the study. Large differences in
the sympathetic response at birth, as determined by RSNA, were also
seen between groups, being significantly greater in ADX + F
animals than in ADX lambs at 1 and 3 h. More specifically, RSNA
almost doubled in ADX + F lambs 1 h after delivery and
remained at this level for the duration of the study. In contrast, RSNA
was similar before and after birth in ADX animals.
|
Effect of adenalectomy and cortisol replacement on baroreflex
control of HR and RSNA.
Cortisol replacement had no effect on the upper or lower plateaus or
the gain (slope) of the fetal HR baroreflex (Table
3 and Fig.
1). The HR baroreflex curve was shifted
to the right in ADX + F compared with ADX fetuses, as indicated by
the significant increase in the curve midpoint pressure (54 ± 3 vs. 45 ± 2 mmHg for ADX + F and ADX, respectively). A
similar effect of cortisol was seen for the fetal RSNA baroreflex
curves with a significant shift to the right for the curve midpoint
pressure in the ADX + F (56 ± 4 mmHg) compared with the ADX
fetus (46 ± 2 mmHg) but no change in the gain or curve plateau
values (Table 4 and Fig. 2).
|
|
|
|
Effect of adenalectomy and cortisol replacement on circulating
hormone concentrations.
In both groups of animals, fetal and newborn plasma epinephrine
concentrations were undetectable. No differences were detected between
fetal values for norepinephrine, ANG II, or AVP (Table 5). After birth, norepinephrine, ANG II,
and AVP significantly increased above fetal values in ADX lambs,
whereas only norepinephrine increased in ADX + F animals. The
postnatal increases in plasma norepinephrine concentrations were
similar in both groups. Plasma cortisol concentrations in ADX animals
were below the level of sensitivity of the assay (~5 ng/ml). In
ADX + F fetuses, plasma cortisol concentration was 58 ± 9 ng/ml at the time of study, and it decreased to 19 ± 8 ng/ml
1 h after delivery and ~90 min after stopping the cortisol
infusion.
|
| |
DISCUSSION |
|---|
|
|
|---|
The results from this study demonstrate that physiological replacement of cortisol in adrenalectomized fetal lambs results in higher fetal blood pressure and greater postnatal increases in HR, MABP, and RSNA. In addition, cortisol replacement results in a resetting or shift of the efferent limb of the HR and RSNA baroreflex toward higher arterial pressure. The immediate postnatal increases in resting HR, MABP, and RSNA and the resetting of the HR and RSNA baroreflex curves are similar to those previously described by this laboratory in intact lambs (31), suggesting that the natural prepartum increase in fetal plasma cortisol concentration is vital for normal autonomic and sympathetic function at birth.
Studies of the ovine fetus demonstrate a progressive increase in fetal plasma cortisol levels during the last 2 wk of gestation that likely prepares the fetus for the transition to extrauterine life (16, 19). The increasing availability of endogenous glucocorticoids late in fetal life modulates the development and rate of differentiation of numerous tissues, the most well studied being the lung. However, fetal adrenal cortisol production also plays an important role in cardiovascular development. Unno et al. (39) reported that bilateral fetal adrenalectomy attenuates the normal gestational age-dependent increase in fetal blood pressure occurring in late gestation, whereas physiological replacement of cortisol produced a sustained increase in blood pressure. Although the rise in fetal blood pressure associated with administration of glucocorticoids appears related to increased peripheral vascular resistance, the mechanisms for this are unclear. In vivo glucocorticoids increase smooth reactivity and enhance pressor responsiveness (2, 6). Cortisol infusion increases the pressor response to intravenous ANG II in intact ovine fetuses, although several studies suggest the peripheral renin-angiotensin system does not mediate the fetal blood pressure response to glucocorticoids (12, 29, 37). Glucocorticoids also reduce the activity of depressor systems, including vasodilator prostaglandins and nitric oxide (41). Clearly, more studies investigating the effects of glucocorticoids and fetal hemodynamic regulation are needed.
Padbury et al. (21) demonstrated that HR, blood pressure, and cardiac output fail to increase after birth in adrenalectomized near-term ovine fetuses. Because replacement doses of hydrocortisone were administered, the authors attributed the attenuated physiological responses to the lack of adrenal epinephrine secretion. Our findings of increased postnatal HR and MABP in ADX + F animals contrast with those of Padbury and suggest that the normal increase in circulating epinephrine is not vital for these responses. The primary difference between the studies is the amount of cortisol replacement. In the Padbury study, plasma cortisol levels were significantly lower in adrenalactomized compared with control animals and below the normal prepartum levels. On the other hand, we achieved plasma cortisol levels well within the physiological range present immediately before delivery. Because newborn systemic hemodynamic measurements in ADX + F animals were similar to those reported by others and us in intact animals, we suggest that adequate levels of circulating glucocorticoids are of primary importance in cardiovascular adaptation at birth (23, 31, 32). Antenatal administration of glucocorticoids augments cardiovascular performance in prematurely delivered lambs, despite these animals' having lower plasma epinephrine levels than controls (22, 30). Taken together, these findings support an important role for glucocorticoids in postnatal hemodynamic adaptation.
The lack of increase in RSNA at birth in ADX animals is similar to that which we previously reported in prematurely delivered lambs (30). Exogenous administration of glucocorticoids, either via physiological replacement of cortisol, as in the present study, or antenatal maternal administration of betamethasone, as performed in our study of prematurely delivered lambs, impacted significantly on the changes in RSNA after birth. Thus corticosteroids appear to have a maturational effect on the sympathetic response at birth inasmuch as steroid-treated animals had increases in RSNA after birth, similar to that seen in intact near-term animals (31). We speculate the augmented sympathetic outflow and enhanced noradrenergic function contribute to the increased postnatal blood pressure seen in these animals.
Relatively little is known about the physiological impact of glucocorticoids on sympathetic function, and no consensus exists as to the effects. The majority of studies in adult animals and humans demonstrate that resting or stimulated sympathetic nerve activity is decreased or unchanged by glucocorticoids (7, 15, 40). Central administration of hydrocortisone acutely increases blood pressure and sympathetic activity in adult rats (36). Our finding of an attenuated RSNA response at birth in ADX relative to ADX + F lambs and intact lambs (31) suggests the effects of glucocorticoids on the sympathetic nervous system may differ depending on the stage of development. Central autonomic function may be influenced by glucocorticoids by the integration of multiple mechanisms, including the regulation of genes encoding neuropeptides and ion channels, neuronal excitability, and neurosecretion (17). Studies in a number of species show that glucocorticoid receptors in the brain are preferentially concentrated within the limbic system, the nucleus of the solitary tract, and the paraventricular nucleus of the hypothalamus, these latter two regions being strongly implicated as cardiovascular control centers (1, 18). In fact, we recently demonstrated that the paraventricular nucleus participates in regulating the sympathoexcitatory response at birth (8). In young rats, glucocorticoids increase phenylethanolamine N-methyltransferase within the hypothalamus, accelerate development of central noradrenergic function, and induce expression of the norepinephrine transporter (33, 34, 38). Alterations in serotonin concentrations, an important central neurotransmitter, are also present in the hypothalamus and brain stem of rat pups exposed to prenatal dexamethasone (17). In addition to influencing the expression of target genes (genomic effects), glucocorticoids may have rapid, nongenomic effects by interacting with specific membrane receptors and involving traditional second messengers. Iontophoretic application of glucocorticoids acutely increases activity of barosensitive cardiovascular neurons in the rostral ventral lateral medulla and has rapid effects on neural activity in the hypothalamus (11, 24). Further studies are required to increase our understanding of these potential effects of glucocorticoids on centrally mediated sympathetic outflow.
The in vivo effects of exogenous administration of glucocorticoids on function of the arterial baroreflex in adult rats have been recently examined. Scheuer and colleagues (26, 28) reported that elevation of corticosterone levels reset baroreflex control of HR and RSNA toward higher pressure and reduced the gain of the responses. These effects were reversed within hours of administering the glucocorticoid type II receptor antagonist mifepristone. We similarly demonstrated in premature fetuses and newborn lambs that antenatal administration of betamethasone decreased the sensitivity of baroreflex-mediated changes in HR to increases in MABP (30). Unno et al. (39) found in adrenalectomized fetuses that cortisol infusion increased blood pressure and basal HR. Although a direct stimulatory effect of cortisol on the heart is possible, this finding is also consistent with a resetting of the baroreflex. In the present study, restoring circulating cortisol levels to the physiological range in ADX animals shifted the baroreflex curves for HR and RSNA to the right without altering the slope of the curves. Resetting of the baroreflex curves immediately after birth was seen in the ADX + F animals, similar to that which we previously described in intact newborn lambs (31). In contrast, no postnatal resetting was seen in the ADX animals. Thus, there are consistent data demonstrating that glucocorticoids influence baroreflex function; this may be one mechanism by which corticosteroids modulate blood pressure.
We did not investigate the mechanism(s) by which glucocorticoid replacement alters baroreflex function. In the present studies, we found no effect of hydrocortisone on the sensitivity of the fetal baroreflex responses, whereas previous studies showed an attenuation of the slope of the reflex curve for HR and RSNA (26, 28, 30). Differences in animal species, experimental conditions, dose of cortisol replacement, and use of anesthetics may contribute to this discrepancy in findings. Resetting of the arterial baroreflex may occur at the level of the baroreceptors (i.e., peripheral resetting) or centrally, via alterations in neuronal activity, activation of other reflex pathways, or changes in the level of circulating hormones that influence autonomic activity. Determining whether the increased resting blood pressure seen in the ADX + F fetuses and newborns relative to the ADX animals contributed to or resulted from resetting of the baroreflex will require additional studies.
Perspectives
Successful transition from the fetal to extrauterine environment involves numerous physiological adaptive responses. Impairment of these responses, which is likely related to immaturity of neurohumoral systems, receptor mechanisms, and end-organ function contributes to the increased morbidity and mortality associated with premature birth. Antenatal glucocorticoid therapy improves pulmonary and cardiovascular homeostasis after birth and lessens the incidence of complications regulated to disordered hemodynamic regulation. Understanding how glucocorticoids regulate autonomic and circulatory function is vital as we aim to provide optimal therapy to these patients. In the present study, we established that the normal pattern of endogenous cortisol production late in gestation is important for postnatal cardiovascular and sympathetic function. Future investigations will allow us to define the mechanisms by which glucocorticoids alter autonomic function and contribute to the pathogenesis of hypertension.| |
ACKNOWLEDGEMENTS |
|---|
The authors gratefully acknowledge the assistance of M. A. Hart in the preparation of this manuscript.
| |
FOOTNOTES |
|---|
This study was supported by National Institutes of Health Grant RO1-HL-59939.
Address for reprint requests and other correspondence: J. L. Segar, Univ. of Iowa, 200 Hawkins Dr., W227 GH, Iowa City, IA 52242 (E-mail: jeffrey-segar{at}uiowa.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
April 18, 2002;10.1152/ajpregu.00056.2002
Received 16 April 2002; accepted in final form 16 April 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Andrews, MH,
and
Matthews SG.
Regulation of glucocorticoid receptor mRNA and heat shock protein 70 mRNA in the developing sheep brain.
Brain Res
878:
174-182,
2000[Web of Science][Medline].
2.
Anwar, MA,
Schwab M,
Poston L,
and
Nathanielsz PW.
Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus.
Am J Physiol Heart Circ Physiol
276:
H1137-H1143,
1999
3.
Ballard, PL.
Glucocorticoids and differentiation.
In: Monograph on Endocrinology, edited by Baxter JD,
and Rousseau GG.. Berlin: Springer-Verlag, 1979, vol. 12, p. 493-515.
4.
Benediktsson, R,
Lindsay RS,
Noble J,
Seckl JR,
and
Edwards CRW
Glucocortoid exposure in utero: new model for adult hypertension.
Lancet
341:
339-341,
1993[Web of Science][Medline].
5.
Derks, JB,
Giussani DA,
Jenkins SL,
Wentworth RA,
Visser GHA,
Padbury JF,
and
Nathanielsz PW.
A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep.
J Physiol
499:
217-226,
1997
6.
Docherty, CC,
Kalmar-Nagy J,
Engelen M,
Koenen SV,
Nijland M,
Kuc RE,
Davenport AP,
and
Nathanelsz PW.
Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1.
Am J Physiol Regulatory Integrative Comp Physiol
281:
R261-R268,
2001
7.
Dodt, C,
Keyser B,
Molle M,
Fehm HL,
and
Elam M.
Acute suppression of muscle sympathetic nerve activity by hydrocortisone in humans.
Hypertension
35:
758-763,
2000
8.
Ellsbury, DL,
Smith OJ,
and
Segar JL.
Ablation of the paraventricular nucleus attenuates sympathoexcitation at birth (Abstract).
Pediatr Res
47:
397,
2000.
9.
Ervin, MG,
Padbury JF,
Polk DH,
Ikegami M,
Berry LM,
and
Jobe AH.
Antenatal glucocorticoids alter premature newborn lamb neuroendocrine and endocrine responses to hypoxia.
Am J Physiol Regulatory Integrative Comp Physiol
279:
R830-R838,
2000
10.
Ervin, MG,
Seidner SR,
Leland MM,
Ikegami M,
and
Jobe AH.
Direct fetal glucocorticoid treatment alters postnatal adaptation in premature newborn baboons.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R1169-R1176,
1998
11.
Falkenstein, E,
Tillmann HC,
Christ M,
Feuring M,
and
Wehling M.
Multiple actions of steroid hormones-a focus on rapid, nongenomic effects.
Pharmacol Rev
52:
513-556,
2000
12.
Hegarty, BD,
Burrell JH,
Gibson KJ,
McMullen JR,
and
Lumbers ER.
Effect of cortisol on fetal ovine vascular angiotensin II receptors and contractility.
Eur J Pharmacol
406:
439-448,
2000[Web of Science][Medline].
13.
Jennings, JJ,
and
Crowley JP.
The influence of mating management on fertility in ewes following progesterone-PMS treatment.
Vet Rec
90:
495-498,
1972[Web of Science][Medline].
14.
Kent, BB,
Drane JW,
Blumenstein B,
and
Manning JW.
A mathematical model to assess changes in the baroreceptor reflex.
Cardiology
57:
295-310,
1972[Web of Science][Medline].
15.
Macefield, VG,
Williamson PM,
Wilson LR,
Kelly JJ,
Gandevia SC,
and
Whitworth JA.
Muscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humans.
Blood Press
7:
215-222,
1998[Medline].
16.
Magyar, DM,
Fridshal D,
Elsner CW,
Eliot J,
Klein AH,
Lowe KC,
Buster JE,
and
Nathanielsz PW.
Time-trend analysis of plasma cortisol concentrations in the fetal sheep in relation to parturition.
Endocrinology
107:
155-159,
1980
17.
Matthews, SG.
Antenatal glucocorticoids and programming of the developing CNS.
Pediatr Res
47:
291-300,
2000[Web of Science][Medline].
18.
Meyer, JS.
Biochemical effects of corticosteroids on neural tissues.
Physiol Rev
65:
946-1020,
1985
19.
Nathanielsz, PW.
Adrenocorticotropin.
In: Fetal Endocrinology: An Experimental Approach, edited by Nathanielsz PW.. Amsterdam: North-Holland Publishing, 1976, p. 125-150.
20.
Nyirenda, MJ,
and
Seckl JR.
Intrauterine events and the programming of adulthood disease: the role of fetal glucocorticoid exposure (review).
Int J Mol Med
2:
607-614,
1998[Web of Science][Medline].
21.
Padbury, J,
Agata Y,
Ludlow J,
Ikegami M,
Baylen B,
and
Humme J.
Effect of fetal adrenalectomy on catecholamine release and physiologic adaptation at birth in sheep.
J Clin Invest
80:
1096-1103,
1987[Web of Science][Medline].
22.
Padbury, JF,
Polk DH,
Ervin G,
Berry LM,
Ikegami M,
and
Jobe AH.
Postnatal cardiovascular and metabolic responses to a single intramuscular dose of betamethasone in fetal sheep born prematurely by cesarean section.
Pediatr Res
38:
709-715,
1995[Web of Science][Medline].
23.
Padbury, JF,
Polk DH,
Newnham JP,
and
Lam RW.
Neonatal adaptation: greater sympathoadrenal response in preterm than full-term fetal sheep at birth.
Am J Physiol Endocrinol Metab
248:
E443-E449,
1985
24.
Rong, W,
Wang W,
Yuan W,
and
Chen Y.
Rapid effects of corticosterone on cardiovascular neurons in the rostral ventrolateral medulla of rats.
Brain Res
815:
51-59,
1999[Web of Science][Medline].
25.
Saruta, T.
Mechanism of glucocorticoid-induced hypertension.
Hypertens Res
19:
1-8,
1996[Medline].
26.
Scheuer, DA,
and
Bechtold AG.
Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive rats.
Am J Physiol Regulatory Integrative Comp Physiol
282:
R475-R483,
2002
27.
Scheuer, DA,
and
Bechtold AG.
Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure.
Am J Physiol Regulatory Integrative Comp Physiol
280:
R1719-R1726,
2001
28.
Scheuer, DA,
and
Mifflin SW.
Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity.
Am J Physiol Regulatory Integrative Comp Physiol
280:
R1440-R1449,
2001
29.
Segar, JL,
Bedell KA,
and
Smith OJ.
Glucocorticoid modulation of cardiovascular and autonomic function in preterm lambs: role of ANG II.
Am J Physiol Regulatory Integrative Comp Physiol
280:
R646-R654,
2001
30.
Segar, JL,
Lumbers ER,
Nuyt AM,
Smith OJ,
and
Robillard JE.
Effect of antenatal glucocorticoids on sympathetic nerve activity at birth in preterm sheep.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R160-R167,
1998
31.
Segar, JL,
Mazursky JE,
and
Robillard JE.
Changes in ovine renal sympathetic nerve activity and baroreflex function at birth.
Am J Physiol Heart Circ Physiol
267:
H1824-H1832,
1994
32.
Segar, JL,
Smith OJ,
and
Holley AT.
Mechano- and chemoreceptor modulation of renal sympathetic nerve activity at birth in fetal sheep.
Am J Physiol Regulatory Integrative Comp Physiol
276:
R1295-R1301,
1999
33.
Slotkin, TA,
Lappi SE,
McCook EC,
Tayyeb MI,
Eylers JP,
and
Seidler FJ.
Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity.
Biol Neonate
61:
326-336,
1992[Web of Science][Medline].
34.
Slotkin, TA,
Lappi SE,
Tayyeb MI,
and
Seidler FJ.
Dose-dependent glucocorticoid effects on noradrenergic synaptogenesis in rat brain: ontogeny of [3H]desmethylimipramine binding sites after fetal exposure to dexamethasone.
Res Commun Chem Pathol Pharmacol
73:
3-19,
1991[Web of Science][Medline].
35.
Smith, FG,
Klinkefus JM,
Kopp UC,
and
Robillard JE.
Novel recordings of renal sympathetic nerve activity in conscious fetal sheep and newborn lambs.
Am J Physiol Renal Fluid Electrolyte Physiol
258:
F218-F221,
1990
36.
Takahashi, H,
Takeda K,
Ashizawa H,
Inoue A,
Yondea S,
Yoshimura M,
and
Ijichi H.
Centrally induced cardiovascular and sympathetic responses to hydrocortisone in rats.
Am J Physiol Heart Circ Physiol
245:
H1013-H1018,
1983
37.
Tangalakis, T,
Lumbers ER,
Moritz KM,
Towstoless MK,
and
Wintour EM.
Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus.
Exp Physiol
77:
709-717,
1992[Abstract].
38.
Turner, BB,
Katz RJ,
and
Carroll BJ.
Neonatal corticosteroid permanently alters brain activity of epinephrine-synthesizing in stressed rats.
Brain Res
166:
426-430,
1979[Web of Science][Medline].
39.
Unno, N,
Wong CH,
Jenkins SL,
Wentworth RA,
Ding XY,
Li C,
Robertson SS,
Smotherman WP,
and
Nathanielsz PW.
Blood pressure and heart rate in the ovine fetus: ontogenic changes and effects of fetal adrenalectomy.
Am J Physiol Heart Circ Physiol
276:
H248-H256,
1999
40.
Waeber, B,
Gavras H,
Bresnahan MR,
Gavras I,
and
Brunner HR.
Role of vasoconstrictor systems in experimental glucocorticoid-hypertension in rats.
Clin Sci (Lond)
65:
255-261,
1983[Medline].
41.
Wallerath, T,
Witte K,
Schäfer SC,
Schwarz PM,
Prellwitz W,
Wohlfart P,
Kleinert H,
Lehr HA,
Lemmer B,
and
Förstermann U.
Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension.
Proc Natl Acad Sci USA
96:
13357-13362,
1999
This article has been cited by other articles:
![]() |
A. G. Bechtold and D. A. Scheuer Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1003 - R1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Scheuer, A. G. Bechtold, S. S. Shank, and S. F. Akana Glucocorticoids act in the dorsal hindbrain to increase arterial pressure Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H458 - H467. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Lumbers, Z.-Y. Yu, and E. N. Crawford Effects of fetal behavioral states on renal sympathetic nerve activity and arterial pressure of unanesthetized fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2003; 285(4): R908 - R916. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |